Regulatory Challenges in the CIS and Russia - TOPRA In CEE WebinarNovember 22, 2023
Bringing the Dossier in Accordance With the Rules of the EAEU
Absolutely all dossiers for medicinal products registered in the EAEU countries must be brought in accordance with the requirements of the Eurasian Economic Union by December 31, 2025.
The Eurasian Economic Commission (EEC) called on pharmaceutical manufacturers to intensify their efforts in this direction.
Pharmaceutical manufacturers have a lot of work to complete in order to finish all procedures by December 31, 2025. To achieve these goals, Inpharmatis offers pharmaceutical manufacturers an optimally planned process for bringing the dossier in line with the EAEU rules, and full support.
Inpharmatis is an international consulting group of companies that provides a full range of services for the registration of medicines and bringing the registration dossier in accordance with the requirements of the EAEU. Highly qualified experts of Inpharmatis have many years of experience of successful work in the EAEU countries and provide full support to the client at every stage of registration. For more information, please contact us firstname.lastname@example.org
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭСNovember 01, 2023
Features of Choosing the Type of PIL RUT in EAEUNovember 01, 2023
PIL Readability User Testing in EAEU Special Autumn OfferOctober 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладышаOctober 24, 2023
PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022